Refine by
System Receives Health Articles & Analysis
291 news found
In an epidemic, better knowledge can lead to wiser policy and can save lives. Can wastewater-based measurements of SARS-CoV-2 activity help us understand the effects of COVID-19 vaccination, and how those effects might change with new variants like Delta? To understand how wastewater can help us better understand the role of vaccines during this Delta wave, we should first look back to how we ...
As 2024 draws to a close, it’s the perfect time to reflect on the incredible strides we’ve made this year – not only as a company but as a team committed to continuous improvement and growth. At Datum Electronics, we firmly believe that investing in our people is key to driving success, and this year’s training and development efforts have been a testament to that ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that the company is joining the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care. SOPHiA GENETICS offers a ...
Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. Michael’s Hospital, with support from OBIO’s Life Sciences ...
Currently, ~30-40% of eligible NSCLC patients do not receive appropriate testing1. In September 2023, Tempus and AstraZeneca initiated a pilot program to leverage Next to identify this specific care gap at participating provider sites, using AI to scan unstructured clinical data to understand which patients may be eligible for testing based on clinical guidelines, and notifying ...
ByTempus
Caresyntax, the leading vendor of enterprise-scale data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2023, as the company has continued its strong growth journey. Dennis Kogan, co-founder, and CEO: “Caresyntax celebrated its 10-year anniversary in 2023 and accelerated our journey of innovation and expansion ...
Caresyntax, the leading vendor-neutral surgical data and intelligence platform converging AI-powered software, devices, and clinical services, today announced the launch of Caresyntax Clinical Data as a Service (CDaaS) for Medtech industry partners. The launch of Caresyntax CDaaS follows the recently announced addition of CQInsights (CQI) and appointment of Dr. Bruce Ramshaw as Chief Medical ...
In the world of healthcare and innovation, where the qualitative and financial pressures are high and the challenges are complex, there exists a unique and exclusive gathering that is working to revolutionize the future of surgery. They are the Caresyntax Future of Surgery Dinners, and they are a unique format for bringing together leaders of health systems, med tech, surgery, insurance, and ...
The U.S. Food and Drug Administration (“FDA”) has announced a new medical device product classification “whole room microbial reduction device” which establishes FDA regulation of UV robots intended to reduce the number of pathogens in unoccupied patient rooms, operating rooms and other areas in healthcare facilities where non-critical medical devices are present. ...
TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that the Company has entered into a contract with Vizient, Inc. increasing TO Mi's presence in the U.S. healthcare system. Vizient is the largest group purchasing organization (GPO) in the healthcare industry supplying around $100 billion in ...
The QUASAR clinical trial will measure changes in best corrected visual acuity (BCVA) in patients who receive aflibercept 8 mg with extended treatment intervals after initial monthly doses and those who receive Eylea (aflibercept 2 mg) every 4 weeks, until the primary endpoint is assessed at week 36. ...
ByBayer AG
High demand seen for effective disease management platform for second most common cancer in Singaporean men NEW YORK and SINGAPORE, March 28, 2022 /PRNewswire/ -- miR Scientific, a New York-based healthcare company dedicated to transforming global cancer management, and Leonie Hill Capital, a Singapore-based organization focused on large-scale, sophisticated healthcare access and distribution, ...
Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. Patients need to trust that their healthcare providers are utilizing their data to advance innovations that will help them in the future. Healthcare providers such as health systems and hospitals must trust external stakeholders to use that data for ...
Finally, we showed the potential for partnered healthcare system research with EHR integration, in this case for tailored care pathways for diverse ...
iRhythm Technologies will have the results of four studies presented by leading clinical investigators at the American Heart Association’s 2022 Scientific Sessions on Nov. 5-7 in Chicago, Illinois. The studies listed below focus on iRhythm’s core suite of Zio XT and AT patch-based extended and mobile cardiac monitoring products and services. Saturday, Nov. 5 3:00 – 4:00 p.m. ...
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that gammaCore Sapphire™, the first and only FDA-cleared, non-invasive device to treat and prevent multiple types of headache pain via the vagus nerve, will be distributed and billed exclusively by Joerns Healthcare, LLC (Joerns) within selected managed care health systems. ...
According to surveys carried out by the GBE project in Benin between 2020-2021, over 69% of solar systems installed at health centres in Benin in the past five years prior were no longer working. With much focus put on installing solar systems at health centres, very little attention is placed on what happens after commissioning. In most cases, due to lack of maintenance and proper care, solar ...
Why should payers care about clinical laboratory testing? Clinical laboratory testing plays an essential role in the delivery of health care. From early detection and diagnosis of disease to individualized treatment plans based on a person’s unique biology, medical care depends on accurate and timely health data. Seventy percent of medical decisions depend on lab test results, so making ...
Meet us from October 12 – 13, 2022 at the Diagnostics-4-Future conference in Konstanz and learn more about our know-how in the fields of contract manufacturing, contract development, lifecycle management and many more. Meet LRE Medical at booth #16 or if you would like to set an appointment, please reach out to Claudia Strehle at strehle@lre.de. Diagnostics-4-Future is an ...
Results of an analysis of a previous prevention trial with Diamyd® (GAD-alum) treatment, which indicate a positive and sustained immunomodulating effect after treatment with Diamyd® in healthy children at risk for type 1 diabetes, have been published in the scientific journal Journal of Immunology Research. The analysis was carried out by researchers at Lund University and provides ...